Back
Leggett & Platt 10K Form
Sell
24
LEG
Leggett & Platt
Last Price:
28.26
Seasonality Move:
-0.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-02-24 | 10K | LEG/Leggett & Platt Annual |
2020-11-05 | 10Q | LEG/Leggett & Platt Quarterly |
2020-08-06 | 10Q | LEG/Leggett & Platt Quarterly |
2020-05-08 | 10Q | LEG/Leggett & Platt Quarterly |
2020-02-20 | 10K | LEG/Leggett & Platt Annual |
2019-11-05 | 10Q | LEG/Leggett & Platt Quarterly |
Receive LEG News And Ratings
See the #1 stock for the next 7 days that we like better than LEG
LEG Financial Statistics
Sales & Book Value
Annual Sales: | $5.15B |
---|---|
Cash Flow: | $80.1M |
Price / Cash Flow: | 9.83 |
Annual Sales: | $12.52 |
Price / Book: | 2.26 |
Profitability
EPS (TTM): | 1.69880 |
---|---|
Net Income (TTM): | $231.9M |
Gross Margin: | $976.8M |
Return on Equity: | 14.23% |
Return on Assets: | 4.46% |
Leggett & Platt Earnings Forecast
Key Leggett & Platt Financial Ratios
- The Gross Profit Margin over the past 39 years for LEG is 18.98%.
- The Selling, General & Administrative Expenses for LEG have been equal to 8.30% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 27.60% of Operating Income.
- The Net Earning history of LEG is 6.02% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 24 years.
Leggett & Platt Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Furnishings, Fixtures & Appliances |
Sector: | Consumer Cyclical |
Current Symbol: | LEG |
CUSIP: | 524660 |
Website: | leggett.com |
Debt
Debt-to-Equity Ratio: | 1.21 |
---|---|
Current Ratio: | 1.99 |
Quick Ratio: | 1.02 |
Price-to-Earnings
Trailing P/E Ratio: | 12.46 |
---|---|
Forward P/E Ratio: | 16.52 |
LEG Technical Analysis vs Fundamental Analysis
Sell
24
Leggett & Platt (LEG)
is a Sell
Is Leggett & Platt a Buy or a Sell?
-
Leggett & Platt stock is rated a Sell
The current Leggett & Platt [LEG] share price is $28.29. The Score for LEG is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.